{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:06:14Z","timestamp":1764986774845,"version":"3.46.0"},"reference-count":19,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China, youth project","award":["81602220"],"award-info":[{"award-number":["81602220"]}]},{"DOI":"10.13039\/501100012166","name":"National key research and development program","doi-asserted-by":"crossref","award":["2019YFC0119100"],"award-info":[{"award-number":["2019YFC0119100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Special Diseases Program of Pudong New Area Health System","award":["PWZzb2017-06"],"award-info":[{"award-number":["PWZzb2017-06"]}]},{"name":"Shanghai Science and technology innovation action plan","award":["18441910900"],"award-info":[{"award-number":["18441910900"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,9,17]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The classical pathway for diagnosing prostate cancer is systematic 12-core biopsy under the guidance of transrectal ultrasound, which tends to underdiagnose the clinically significant tumour and overdiagnose the insignificant disease. Another pathway named targeted biopsy is using multiparametric MRI to localise the tumour precisely and then obtain the samples from the suspicious lesions. Targeted biopsy, which is mainly divided into cognitive fusion method and software-based fusion method, is getting prevalent for its good performance in detecting significant cancer. However, the preferred targeted biopsy technique in detecting clinically significant prostate cancer between cognitive fusion and software-based fusion is still beyond consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This trial is a prospective, single-centre, randomised controlled and non-inferiority study in which all men suspicious to have clinically significant prostate cancer are included. This study aims to determine whether a novel three-dimensional matrix positioning cognitive fusion-targeted biopsy is non-inferior to software-based fusion-targeted biopsy in the detection rate of clinically significant cancer in men without a prior biopsy. The main inclusion criteria are men with elevated serum prostate-specific antigen above 4\u201320 ng\/mL or with an abnormal digital rectal examination and have never had a biopsy before. A sample size of 602 participants allowing for a 10% loss will be recruited. All patients will undergo a multiparametric MRI examination, and those who fail to be found with a suspicious lesion, with the anticipation of half of the total number, will be dropped. The remaining participants will be randomly allocated to cognitive fusion-targeted biopsy (n=137) and software-based fusion-targeted biopsy (n=137). The primary outcome is the detection rate of clinically significant prostate cancer for cognitive fusion-targeted biopsy and software-based fusion-targeted biopsy in men without a prior biopsy. The clinically significant prostate cancer will be defined as the International Society of Urological Pathology grade group 2 or higher.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval was obtained from the ethics committee of Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. The results of the study will be disseminated and published in international peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04271527\">NCT04271527<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-041427","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T12:51:42Z","timestamp":1612702302000},"page":"e041427","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Study protocol for a single-centre non-inferior randomised controlled trial on a novel three-dimensional matrix positioning-based cognitive fusion-targeted biopsy and software-based fusion-targeted biopsy for the detection rate of clinically significant prostate cancer in men without a prior biopsy"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04271527","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-7290","authenticated-orcid":false,"given":"Biming","family":"He","sequence":"first","affiliation":[{"name":"Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongbing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2025120518010890000_11.2.e041427.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2025120518010890000_11.2.e041427.2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv436"},{"key":"2025120518010890000_11.2.e041427.3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.juro.2014.10.084","article-title":"Patterns of repeat prostate biopsy in contemporary clinical practice","volume":"193","author":"Abraham","year":"2015","journal-title":"J Urol"},{"key":"2025120518010890000_11.2.e041427.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32401-1"},{"key":"2025120518010890000_11.2.e041427.5","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"2025120518010890000_11.2.e041427.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.03.005","article-title":"Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer","volume":"34","author":"Tyson","year":"2016","journal-title":"Urol Oncol"},{"key":"2025120518010890000_11.2.e041427.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.17942"},{"key":"2025120518010890000_11.2.e041427.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.08.095"},{"key":"2025120518010890000_11.2.e041427.9","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13121501"},{"key":"2025120518010890000_11.2.e041427.10","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-018-02622-5","article-title":"Controversies in Mr targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?","volume":"37","author":"Marra","year":"2019","journal-title":"World J Urol"},{"key":"2025120518010890000_11.2.e041427.11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2018.11.040","article-title":"The future trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies","volume":"75","author":"Wegelin","year":"2019","journal-title":"Eur Urol"},{"key":"2025120518010890000_11.2.e041427.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.10.048"},{"key":"2025120518010890000_11.2.e041427.13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00345-018-2189-7","article-title":"Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy","volume":"36","author":"Kaufmann","year":"2018","journal-title":"World J Urol"},{"key":"2025120518010890000_11.2.e041427.14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4103\/aja.aja_83_19","article-title":"Initial experience with a novel method for cognitive transperineal magnetic resonance imaging-targeted prostate biopsy","volume":"22","author":"Wang","year":"2020","journal-title":"Asian J Androl"},{"key":"2025120518010890000_11.2.e041427.15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530"},{"key":"2025120518010890000_11.2.e041427.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"2025120518010890000_11.2.e041427.17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00758","article-title":"Trans-perineal template-guided mapping biopsy vs. freehand trans-perineal biopsy in Chinese patients with PSA","volume":"9","author":"He","year":"2019","journal-title":"Front Oncol"},{"key":"2025120518010890000_11.2.e041427.18","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-019-08111-2","article-title":"A novel prediction tool based on multiparametric magnetic resonance imaging to determine the biopsy strategy for clinically significant prostate cancer in patients with PSA levels less than 50 ng\/ml","volume":"27","author":"He","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025120518010890000_11.2.e041427.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2018.05.003","article-title":"Validation of prostate imaging reporting and data system version 2 for the detection of prostate cancer","volume":"200","author":"Hofbauer","year":"2018","journal-title":"J Urol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-041427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:01:13Z","timestamp":1764986473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-041427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bmjopen-2020-041427"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-041427","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}